Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Current Assets (2017 - 2025)

Inspire Medical Systems' Current Assets history spans 9 years, with the latest figure at $583.7 million for Q4 2025.

  • For Q4 2025, Current Assets fell 7.48% year-over-year to $583.7 million; the TTM value through Dec 2025 reached $583.7 million, down 7.48%, while the annual FY2025 figure was $583.7 million, 7.48% down from the prior year.
  • Current Assets for Q4 2025 was $583.7 million at Inspire Medical Systems, roughly flat from $586.5 million in the prior quarter.
  • Across five years, Current Assets topped out at $630.8 million in Q4 2024 and bottomed at $249.5 million in Q2 2021.
  • The 5-year median for Current Assets is $564.8 million (2023), against an average of $477.5 million.
  • The largest annual shift saw Current Assets soared 112.85% in 2023 before it dropped 7.48% in 2025.
  • A 5-year view of Current Assets shows it stood at $268.5 million in 2021, then soared by 97.38% to $530.0 million in 2022, then rose by 12.02% to $593.7 million in 2023, then rose by 6.24% to $630.8 million in 2024, then decreased by 7.48% to $583.7 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Current Assets are $583.7 million (Q4 2025), $586.5 million (Q3 2025), and $573.2 million (Q2 2025).